Traumatic Brain Injury - Pipeline Review, H2 2017

Publisher Name :
Date: 11-Jul-2017
No. of pages: 252
Inquire Before Buying

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H2 2017, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape.

Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping and memory or concentration problems. Risk factor includes age. Certain types of traumatic brain injury increase the risk of developing Alzheimer's disease and coordination problems.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Traumatic Brain Injury - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Traumatic Brain Injury (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 6, 9, 55 and 8 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 10 and 1 molecules, respectively.

Traumatic Brain Injury (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Traumatic Brain Injury (Central Nervous System).

  • The pipeline guide reviews pipeline therapeutics for Traumatic Brain Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

  • The pipeline guide reviews key companies involved in Traumatic Brain Injury (Central Nervous System) therapeutics and enlists all their major and minor projects.

  • The pipeline guide evaluates Traumatic Brain Injury (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

  • The pipeline guide reviews latest news related to pipeline therapeutics for Traumatic Brain Injury (Central Nervous System)

Reasons to buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

  • Find and recognize significant and varied types of therapeutics under development for Traumatic Brain Injury (Central Nervous System).

  • Classify potential new clients or partners in the target demographic.

  • Develop tactical initiatives by understanding the focus areas of leading companies.

  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

  • Formulate corrective measures for pipeline projects by understanding Traumatic Brain Injury (Central Nervous System) pipeline depth and focus of Indication therapeutics.

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Traumatic Brain Injury - Pipeline Review, H2 2017

Table of Contents

Table of Contents 2
Introduction 5
Traumatic Brain Injury - Overview 6
Traumatic Brain Injury - Therapeutics Development 7
Traumatic Brain Injury - Therapeutics Assessment 19
Traumatic Brain Injury - Companies Involved in Therapeutics Development 31
Traumatic Brain Injury - Drug Profiles 52
Traumatic Brain Injury - Dormant Projects 227
Traumatic Brain Injury - Discontinued Products 230
Traumatic Brain Injury - Product Development Milestones 231
Appendix 242

List of Tables

Number of Products under Development for Traumatic Brain Injury, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..3), H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Products under Development by Companies, H2 2017 (Contd..3), H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Target, H2 2017 (Contd..2), H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..2), H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Traumatic Brain Injury - Pipeline by ALSP Inc, H2 2017
Traumatic Brain Injury - Pipeline by Apollo Endosurgery Inc, H2 2017
Traumatic Brain Injury - Pipeline by Aptinyx Inc, H2 2017
Traumatic Brain Injury - Pipeline by Athersys Inc, H2 2017
Traumatic Brain Injury - Pipeline by Beech Tree Labs Inc, H2 2017
Traumatic Brain Injury - Pipeline by Biogen Inc, H2 2017
Traumatic Brain Injury - Pipeline by Cantex Pharmaceuticals Inc, H2 2017
Traumatic Brain Injury - Pipeline by Cognosci Inc, H2 2017
Traumatic Brain Injury - Pipeline by Eustralis Pharmaceuticals Ltd, H2 2017
Traumatic Brain Injury - Pipeline by Intellect Neurosciences Inc, H2 2017
Traumatic Brain Injury - Pipeline by International Stem Cell Corp, H2 2017
Traumatic Brain Injury - Pipeline by Ischemix Inc, H2 2017
Traumatic Brain Injury - Pipeline by JT Pharmaceuticals Inc, H2 2017
Traumatic Brain Injury - Pipeline by Karyopharm Therapeutics Inc, H2 2017
Traumatic Brain Injury - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2017
Traumatic Brain Injury - Pipeline by Levolta Pharmaceuticals Inc, H2 2017
Traumatic Brain Injury - Pipeline by Lixte Biotechnology Holdings Inc, H2 2017
Traumatic Brain Injury - Pipeline by MandalMed Inc, H2 2017
Traumatic Brain Injury - Pipeline by Mapreg SAS, H2 2017
Traumatic Brain Injury - Pipeline by Neuralstem Inc, H2 2017
Traumatic Brain Injury - Pipeline by Neuren Pharmaceuticals Ltd, H2 2017
Traumatic Brain Injury - Pipeline by Neurofx Inc, H2 2017
Traumatic Brain Injury - Pipeline by NeuroNascent Inc, H2 2017
Traumatic Brain Injury - Pipeline by NeuroVive Pharmaceutical AB, H2 2017
Traumatic Brain Injury - Pipeline by New World Laboratories Inc, H2 2017
Traumatic Brain Injury - Pipeline by NoNO Inc, H2 2017
Traumatic Brain Injury - Pipeline by NuvOx Pharma LLC, H2 2017
Traumatic Brain Injury - Pipeline by Omeros Corp, H2 2017
Traumatic Brain Injury - Pipeline by Oxeia Biopharmaceuticals Inc, H2 2017
Traumatic Brain Injury - Pipeline by Prevacus Inc, H2 2017
Traumatic Brain Injury - Pipeline by QR Pharma Inc, H2 2017
Traumatic Brain Injury - Pipeline by RegeneRx Biopharmaceuticals Inc, H2 2017
Traumatic Brain Injury - Pipeline by Rubicon Biotechnology Inc, H2 2017
Traumatic Brain Injury - Pipeline by Sage Therapeutics Inc, H2 2017
Traumatic Brain Injury - Pipeline by SanBio Inc, H2 2017
Traumatic Brain Injury - Pipeline by STATegics Inc, H2 2017
Traumatic Brain Injury - Pipeline by Stemedica Cell Technologies Inc, H2 2017
Traumatic Brain Injury - Pipeline by SynZyme Technologies LLC, H2 2017
Traumatic Brain Injury - Pipeline by Tetra Discovery Partners LLC, H2 2017
Traumatic Brain Injury - Pipeline by vasopharm GmbH, H2 2017
Traumatic Brain Injury - Pipeline by VG Life Sciences Inc, H2 2017
Traumatic Brain Injury - Dormant Projects, H2 2017
Traumatic Brain Injury - Dormant Projects, H2 2017 (Contd..1), H2 2017
Traumatic Brain Injury - Dormant Projects, H2 2017 (Contd..2), H2 2017
Traumatic Brain Injury - Discontinued Products, H2 2017

List of Figures

Number of Products under Development for Traumatic Brain Injury, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Top 10 Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Top 10 Routes of Administration, H2 2017
Number of Products by Stage and Top 10 Routes of Administration, H2 2017
Number of Products by Top 10 Molecule Types, H2 2017
Number of Products by Stage and Top 10 Molecule Types, H2 2017
  • Global and Regional Gabapentin Market Research Report 2017
    Published: 17-Oct-2017        Price: US 3500 Onwards        Pages: 122
    Summary Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Tablet - Capsule By Application - Nerve Pain......
  • Rett Syndrome - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 120
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rett Syndrome - Pipeline Review, H2 2017, provides an overview of the Rett Syndrome (Central Nervous System) pipeline landscape.Rett syndrome is a neurodevelopmental disorder. This is caused by genetic mutation on MECP2 gene. Rett syndrome is described in four stages: Stage I or early onset, Stage II or rapid destruction, Stage III, or the plateau and Stage IV, or the late motor deterioration stage. Symptoms i......
  • Guillain-Barre Syndrome - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 46
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Guillain-Barre Syndrome - Pipeline Review, H2 2017, provides an overview of the Guillain-Barre Syndrome (Central Nervous System) pipeline landscape.Guillain-Barre syndrome (GBS) is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms of this disorder include varying degrees of weakness or tingling sensations in the legs. In many instances the symmetrica......
  • Narcolepsy - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 76
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape.Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling.......
  • Global Learning Disability Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Learning Disability Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides......
  • Global Smoking Cessation Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Smoking Cessation Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides u......
  • Global Neuralgia Partnering 2010-2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Neuralgia Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understan......
  • Global Attention Deficit Disorder Partnering 2010-2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Attention Deficit Disorder Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report p......
  • Global Autism Partnering 2010-2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Autism Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understandin......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs